Therapeutic effects of dihydroartemisinin and transferrin against glioblastoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECFTIVES: Artemisinin, a natural product isolated from Gaeddongssuk (artemisia annua L.) and its main active derivative, dihydroartemisinin (DHA), have long been used as antimalarial drugs. Recent studies reported that artemisinin is efficacious for curing diseases, including cancers, and for improving the immune system. Many researchers have shown the therapeutic effects of artemisinin on tumors such as breast cancer, liver cancer and kidney cancer, but there is still insufficient data regarding glioblastoma (GBM). Glioblastoma accounts for 12-15% of brain cancer, and the median survival is less than a year, despite medical treatments such as surgery, radiation therapy, and chemotherapy. In this study, we investigated the anti-cancer effects of DHA and transferrin against glioblastoma (glioblastoma multiforme, GBM). MATERIALS/METHODS: This study was performed through in vitro experiments using C6 cells. The toxicity dependence of DHA and transferrin (TF) on time and concentration was analyzed by MTT assay and cell cycle assay. Observations of cellular morphology were recorded with an optical microscope and color digital camera. The anti-cancer mechanism of DHA and TF against GBM were studied by flow cytometry with Annexin V and caspase 3/7. RESULTS: MTT assay revealed that TF enhanced the cytotoxicity of DHA against C6 cells. An Annexin V immune-precipitation assay showed that the percentages of apoptosis of cells treated with TF, DHA alone, DHA in combination with TF, and the control group were 7.15 ± 4.15%, 34.3 ± 5.15%, 66.42 ± 5.98%, and 1.2 ± 0.15%, respectively. The results of the Annexin V assay were consistent with those of the MTT assay. DHA induced apoptosis in C6 cells through DNA damage, and TF enhanced the effects of DHA. CONCLUSION: The results of this study demonstrated that DHA, the derivative of the active ingredient in Gaeddongssuk, is effective against GBM, apparently via inhibition of cancer cell proliferation by a pharmacological effect. The role of transferrin as an allosteric activator in the GBM therapeutic efficacy of DHA was also confirmed.
Abstract
BACKGROUND/OBJECFTIVES: Artemisinin, a natural product isolated from Gaeddongssuk (artemisia annua L.) and its main active derivative, dihydroartemisinin (DHA), have long been used as antimalarial drugs. Recent studies reported that artemisinin is efficacious for curing diseases, including cancers, and for improving the immune system. Many researchers have shown the therapeutic effects of artemisinin on tumors such as breast cancer, liver cancer and kidney cancer, but there is still insufficient data regarding glioblastoma (GBM). Glioblastoma accounts for 12-15% of brain cancer, and the median survival is less than a year, despite medical treatments such as surgery, radiation therapy, and chemotherapy. In this study, we investigated the anti-cancer effects of DHA and transferrin against glioblastoma (glioblastoma multiforme, GBM). MATERIALS/METHODS: This study was performed through in vitro experiments using C6 cells. The toxicity dependence of DHA and transferrin (TF) on time and concentration was analyzed by MTT assay and cell cycle assay. Observations of cellular morphology were recorded with an optical microscope and color digital camera. The anti-cancer mechanism of DHA and TF against GBM were studied by flow cytometry with Annexin V and caspase 3/7. RESULTS: MTT assay revealed that TF enhanced the cytotoxicity of DHA against C6 cells. An Annexin V immune-precipitation assay showed that the percentages of apoptosis of cells treated with TF, DHA alone, DHA in combination with TF, and the control group were 7.15 ± 4.15%, 34.3 ± 5.15%, 66.42 ± 5.98%, and 1.2 ± 0.15%, respectively. The results of the Annexin V assay were consistent with those of the MTT assay. DHA induced apoptosis in C6 cells through DNA damage, and TF enhanced the effects of DHA. CONCLUSION: The results of this study demonstrated that DHA, the derivative of the active ingredient in Gaeddongssuk, is effective against GBM, apparently via inhibition of cancer cell proliferation by a pharmacological effect. The role of transferrin as an allosteric activator in the GBM therapeutic efficacy of DHA was also confirmed.
참고문헌 (18)
- Huang L, "Antipyretic and anti-inflammatory effects of Artemisia annua L", Zhongguo Zhong Yao Za Zhi, 18, pp.44~48 (1993)
- Juteau F, "Antibacterial and antioxidant activities of Artemisia annua essential oil", Fitoterapia, 73, pp.532~535 (2002)
- Habib M, "Evaluation of anti-nociceptive, anti-inflammatory and antipyretic activities of Artemisia scoparia hydromethanolic extract", J Ethnopharmacol, 145, pp.18~24 (2013)
- Sen R, "Artemisinin triggers induction of cell-cycle arrest and apoptosis in Leishmania donovani promastigotes", J Med Microbiol, 56, pp.1213~1218 (2007)
- Gao X, "Dihydroartemisinin induces endoplasmic reticulum stress-mediated apoptosis in HepG2human hepatoma cells", Tumori, 97, pp.771~780 (2011)
- Chaturvedi D, "Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents", Chem Soc Rev, 39, pp.435~454 (2010)
- Chertok B, "Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors", Biomaterials, 29, pp.487~496 (2008)
- Stupp R, "Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma", N Engl J Med, 352, pp.987~996 (2005)
- Kim SJ, "Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro", J Cancer Res Clin Oncol, 132, pp.129~135 (2006)
- Chen H, "Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo", Anticancer Drugs, 20, pp.131~140 (2009)
- Wu ZP, "Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model", Integr Cancer Ther, 8, pp.88~92 (2009)
- Lai H, "Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin", Cancer Lett, 91, pp.41~46 (1995)
- Singh NP, "Artemisinin induces apoptosis in human cancer cells", Anticancer Res, 24, pp.2277~2280 (2004)
- van Agtmael MA, "Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication", Trends Pharmacol Sci, 20, pp.199~205 (1999)
- Tan W, "Anti-cancer natural products isolated from Chinese medicinal herbs", Chin Med, 6, pp.27~42 (2011)
- Chen HH, "Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro", Pharmacol Res, 48, pp.231~236 (2003)
- Singh NP, "Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells", Life Sci, 70, pp.49~56 (2001)
- Singh NP, "Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells", Anticancer Res, 25(6B), pp.4325~4331 (2005)